מדינה: אירלנד
שפה: אנגלית
מקור: HPRA (Health Products Regulatory Authority)
OLMESARTAN MEDOXOMIL ; AMLODIPINE AS AMLODIPINE BESILATE; HYDROCHLOROTHIAZIDE
LTT Pharma Limited
C09DX03
OLMESARTAN MEDOXOMIL ; AMLODIPINE AS AMLODIPINE BESILATE; HYDROCHLOROTHIAZIDE
20/5/12.5 Milligram
Film Coated Tablet
Product subject to prescription which may be renewed (B)
olmesartan medoxomil, amlodipine and hydrochlorothiazide
Authorised
2016-09-02
KONVERGE PLUS 20 MG/5 MG/12.5 MG FILM-COATED TABLETS PACKAGE LEAFLET: INFORMATION FOR THE PATIENT THIS MEDICINAL PRODUCT IS AUTHORISED IN THE MEMBER STATES OF THE EEA UNDER THE FOLLOWING NAMES: Austria: Amelior plus HCT 20 mg/5 mg/12.5 mg Belgium: Forzaten/HCT 20 mg/5 mg/12.5 mg Bulgaria: Tespadan HCT 20 mg/5 mg/12.5 mg Cyprus: Orizal plus 20 mg/5 mg/12.5 mg Czech Republic: Sintonyn Combi 20 mg/5 mg/12.5mg Denmark: Alea COMP 20 mg/5 mg/12.5 mg Estonia: Sanoral HCT 20 mg/5 mg/12.5 mg Finland: Alea COMP 20 mg/5 mg/12.5 mg France: TRIAXELER 20 mg/5 mg/12.5 mg Germany: Vocado HCT 20 mg/5 mg/12.5 mg Greece: Orizal plus 20 mg/5 mg/12.5 mg Hungary: Duactan HCT 20 mg/5 mg/12.5 mg Iceland: Alea COMP 20 mg/5 mg/12.5 mg Ireland: Konverge Plus 20 mg/5 mg/12.5 mg Italy: Trivis 20 mg/5 mg/12.5 mg Latvia: Sanoral HCT 20 mg/5 mg/12.5 mg Lithuania: Sanoral HCT 20 mg/5 mg/12.5 mg Luxembourg: Forzaten/HCT 20 mg/5 mg/12.5 mg The Netherlands: Belfor HCT 20 mg/5 mg/12.5 mg Malta: Konverge Plus 20 mg/5 mg/12.5 mg Norway: Alea COMP 20 mg/5 mg/12.5 mg Poland: Elestar HCT 20 mg/5 mg/12.5 mg Portugal: Zolnor HCT 20 mg/5 mg/12.5 mg Romania: Inovum HCT 20 mg/5 mg/12.5 mg Slovak Republic: Folgan HCT 20 mg/5 mg/12.5 mg Slovenia: Olectan HCT 20 mg/5 mg/12.5 mg Spain: Balzak plus 20 mg/5 mg/12.5 mg Konverge Plus is a DAIICHI SANKYO COMPANY, LIMITED. PPA1562/174/001 Revision date: 03/10/2016 Ref: 174/001/031016/1/F ® (OLMESARTAN MEDOXOMIL/AMLODIPINE/HYDROCHLOROTHIAZIDE) Page 1 Page 4 READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. * Keep this leaflet. You may need to read it again. * If you have any further questions, ask your doctor or pharmacist. * This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. * If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET What קרא את המסמך השלם
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Konverge Plus 20 mg/5 mg/12.5 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 20 mg olmesartan medoxomil, 5 mg amlodipine (as amlodipine besilate) and 12.5 mg hydrochlorothiazide. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet _Product imported from Greece_ Light orange, round, film-coated tablet of 8 mm debossed C51 on one side. 4 CLINICAL PARTICULARS As per PA0865/019/001 5 PHARMACOLOGICAL PROPERTIES As per PA0865/019/001 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Tablet core: Pregelatinized maize starch, Silicified microcrystalline cellulose (microcrystalline cellulose and silica colloidal anhydrous), Croscarmellose sodium, Magnesium stearate Film coat: Polyvinyl alcohol, Macrogol 3350, Talc, Titanium dioxide (E 171), Yellow iron oxide (E 172) Red iron oxide (III) (E 172) Black iron oxide (II, III) (E 172) 6.2 INCOMPATIBILITIES Not applicable. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _9_ _/_ _1_ _1_ _/_ _2_ _0_ _1_ _6_ _C_ _R_ _N_ _ _ _2_ _1_ _8_ _4_ _4_ _7_ _4_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 6.3 SHELF LIFE The shelf life expiry date for this product shall be the date shown on the blister and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE This medicinal product does not require any special storage conditions. 6.5 NATUR קרא את המסמך השלם